Cargando…
Increased GH/IGF-I Axis Activity Relates to Lower Hepatic Lipids and Phosphor Metabolism
CONTEXT: Non-alcoholic fatty liver disease (NAFLD) is a leading causes of liver-related morbidity and mortality. While data on acromegaly, a state of chronic growth hormone (GH)/insulin-like growth factor I (IGF-I) excess, suggest an inverse relationship with intrahepatic lipid (IHL) content, less i...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505545/ https://www.ncbi.nlm.nih.gov/pubmed/37104943 http://dx.doi.org/10.1210/clinem/dgad206 |
_version_ | 1785106933012758528 |
---|---|
author | Fellinger, Paul Beiglböck, Hannes Semmler, Georg Pfleger, Lorenz Smajis, Sabina Baumgartner, Clemens Gajdosik, Martin Marculescu, Rodrig Vila, Greisa Winhofer, Yvonne Scherer, Thomas Trauner, Michael Kautzky-Willer, Alexandra Krssak, Martin Krebs, Michael Wolf, Peter |
author_facet | Fellinger, Paul Beiglböck, Hannes Semmler, Georg Pfleger, Lorenz Smajis, Sabina Baumgartner, Clemens Gajdosik, Martin Marculescu, Rodrig Vila, Greisa Winhofer, Yvonne Scherer, Thomas Trauner, Michael Kautzky-Willer, Alexandra Krssak, Martin Krebs, Michael Wolf, Peter |
author_sort | Fellinger, Paul |
collection | PubMed |
description | CONTEXT: Non-alcoholic fatty liver disease (NAFLD) is a leading causes of liver-related morbidity and mortality. While data on acromegaly, a state of chronic growth hormone (GH)/insulin-like growth factor I (IGF-I) excess, suggest an inverse relationship with intrahepatic lipid (IHL) content, less is known about the impact of the GH/IGF-I axis on IHL, lipid composition, and phosphor metabolites in individuals without disorders of GH secretion. OBJECTIVE: The aim was to investigate the relation between activity of the GH/IGF-I axis and IHL content and phosphor metabolism. METHODS: We performed a cross-sectional study in 59 otherwise metabolically healthy individuals (30 females), of which 16 met the criteria of NAFLD with IHL of ≥5.6%. The GH/IGF-I axis was evaluated in a fasting state and during an oral glucose tolerance test (OGTT). Insulin sensitivity was estimated by validated indices. IHL, lipid composition (unsaturation index), and phosphate metabolites were analyzed by using (1)H/(31)P magnetic resonance spectroscopy. RESULTS: In the overall cohort (40.6 ± 15 years; body mass index: 24.5 ± 3 kg/m(2); IGF-I: 68.0 ± 17% upper limit of normal), fasting GH (R = −0.31; P = .02), GH during oral glucose tolerance test (R = −0.51; P < .01), and IGF-I (R = −0.28; P = .03) inversely correlated with IHL. GH levels during OGTT were significantly lower in NAFLD than in controls (47.7 [22; 143] ng/mL/min vs 16.8 [7; 32] ng/mL/min; P = .003). GH/IGF-I axis activity correlated with lipid composition and with phosphor metabolites. In multiple regression analysis, the GH/IGF-I axis activity was a strong predictor for IHL and lipid composition independent from insulin sensitivity. CONCLUSION: GH/IGF-I axis activity impacts hepatic lipid and phosphate metabolism in individuals without disorders in GH secretion. Lower GH axis activity is associated with higher IHL and an unfavorable lipid composition, probably mediated by changes in hepatic energy metabolism. |
format | Online Article Text |
id | pubmed-10505545 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-105055452023-09-19 Increased GH/IGF-I Axis Activity Relates to Lower Hepatic Lipids and Phosphor Metabolism Fellinger, Paul Beiglböck, Hannes Semmler, Georg Pfleger, Lorenz Smajis, Sabina Baumgartner, Clemens Gajdosik, Martin Marculescu, Rodrig Vila, Greisa Winhofer, Yvonne Scherer, Thomas Trauner, Michael Kautzky-Willer, Alexandra Krssak, Martin Krebs, Michael Wolf, Peter J Clin Endocrinol Metab Clinical Research Article CONTEXT: Non-alcoholic fatty liver disease (NAFLD) is a leading causes of liver-related morbidity and mortality. While data on acromegaly, a state of chronic growth hormone (GH)/insulin-like growth factor I (IGF-I) excess, suggest an inverse relationship with intrahepatic lipid (IHL) content, less is known about the impact of the GH/IGF-I axis on IHL, lipid composition, and phosphor metabolites in individuals without disorders of GH secretion. OBJECTIVE: The aim was to investigate the relation between activity of the GH/IGF-I axis and IHL content and phosphor metabolism. METHODS: We performed a cross-sectional study in 59 otherwise metabolically healthy individuals (30 females), of which 16 met the criteria of NAFLD with IHL of ≥5.6%. The GH/IGF-I axis was evaluated in a fasting state and during an oral glucose tolerance test (OGTT). Insulin sensitivity was estimated by validated indices. IHL, lipid composition (unsaturation index), and phosphate metabolites were analyzed by using (1)H/(31)P magnetic resonance spectroscopy. RESULTS: In the overall cohort (40.6 ± 15 years; body mass index: 24.5 ± 3 kg/m(2); IGF-I: 68.0 ± 17% upper limit of normal), fasting GH (R = −0.31; P = .02), GH during oral glucose tolerance test (R = −0.51; P < .01), and IGF-I (R = −0.28; P = .03) inversely correlated with IHL. GH levels during OGTT were significantly lower in NAFLD than in controls (47.7 [22; 143] ng/mL/min vs 16.8 [7; 32] ng/mL/min; P = .003). GH/IGF-I axis activity correlated with lipid composition and with phosphor metabolites. In multiple regression analysis, the GH/IGF-I axis activity was a strong predictor for IHL and lipid composition independent from insulin sensitivity. CONCLUSION: GH/IGF-I axis activity impacts hepatic lipid and phosphate metabolism in individuals without disorders in GH secretion. Lower GH axis activity is associated with higher IHL and an unfavorable lipid composition, probably mediated by changes in hepatic energy metabolism. Oxford University Press 2023-04-27 /pmc/articles/PMC10505545/ /pubmed/37104943 http://dx.doi.org/10.1210/clinem/dgad206 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Research Article Fellinger, Paul Beiglböck, Hannes Semmler, Georg Pfleger, Lorenz Smajis, Sabina Baumgartner, Clemens Gajdosik, Martin Marculescu, Rodrig Vila, Greisa Winhofer, Yvonne Scherer, Thomas Trauner, Michael Kautzky-Willer, Alexandra Krssak, Martin Krebs, Michael Wolf, Peter Increased GH/IGF-I Axis Activity Relates to Lower Hepatic Lipids and Phosphor Metabolism |
title | Increased GH/IGF-I Axis Activity Relates to Lower Hepatic Lipids and Phosphor Metabolism |
title_full | Increased GH/IGF-I Axis Activity Relates to Lower Hepatic Lipids and Phosphor Metabolism |
title_fullStr | Increased GH/IGF-I Axis Activity Relates to Lower Hepatic Lipids and Phosphor Metabolism |
title_full_unstemmed | Increased GH/IGF-I Axis Activity Relates to Lower Hepatic Lipids and Phosphor Metabolism |
title_short | Increased GH/IGF-I Axis Activity Relates to Lower Hepatic Lipids and Phosphor Metabolism |
title_sort | increased gh/igf-i axis activity relates to lower hepatic lipids and phosphor metabolism |
topic | Clinical Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505545/ https://www.ncbi.nlm.nih.gov/pubmed/37104943 http://dx.doi.org/10.1210/clinem/dgad206 |
work_keys_str_mv | AT fellingerpaul increasedghigfiaxisactivityrelatestolowerhepaticlipidsandphosphormetabolism AT beiglbockhannes increasedghigfiaxisactivityrelatestolowerhepaticlipidsandphosphormetabolism AT semmlergeorg increasedghigfiaxisactivityrelatestolowerhepaticlipidsandphosphormetabolism AT pflegerlorenz increasedghigfiaxisactivityrelatestolowerhepaticlipidsandphosphormetabolism AT smajissabina increasedghigfiaxisactivityrelatestolowerhepaticlipidsandphosphormetabolism AT baumgartnerclemens increasedghigfiaxisactivityrelatestolowerhepaticlipidsandphosphormetabolism AT gajdosikmartin increasedghigfiaxisactivityrelatestolowerhepaticlipidsandphosphormetabolism AT marculescurodrig increasedghigfiaxisactivityrelatestolowerhepaticlipidsandphosphormetabolism AT vilagreisa increasedghigfiaxisactivityrelatestolowerhepaticlipidsandphosphormetabolism AT winhoferyvonne increasedghigfiaxisactivityrelatestolowerhepaticlipidsandphosphormetabolism AT schererthomas increasedghigfiaxisactivityrelatestolowerhepaticlipidsandphosphormetabolism AT traunermichael increasedghigfiaxisactivityrelatestolowerhepaticlipidsandphosphormetabolism AT kautzkywilleralexandra increasedghigfiaxisactivityrelatestolowerhepaticlipidsandphosphormetabolism AT krssakmartin increasedghigfiaxisactivityrelatestolowerhepaticlipidsandphosphormetabolism AT krebsmichael increasedghigfiaxisactivityrelatestolowerhepaticlipidsandphosphormetabolism AT wolfpeter increasedghigfiaxisactivityrelatestolowerhepaticlipidsandphosphormetabolism |